Skip to content

Clinical trials

Phase 3 Acquired Immunodeficiency Syndrome trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Phase: Phase 3 Country / region: France Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20041
20051
20061
20072
20084
20101
20117
20122
20132
20152
20163
20181
20191
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Active, not recruiting3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ViiV Healthcare13
Gilead Sciences4
Tibotec Pharmaceuticals, Ireland4
ANRS, Emerging Infectious Diseases2
GlaxoSmithKline2
Janssen R&D Ireland2
Abbott1
Bristol-Myers Squibb1
French National Agency for Research on AIDS and Viral Hepatitis1
Janssen Sciences Ireland UC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome35
HIV Infections19
Infections11
Cytomegalovirus Infections1
Hepatitis B1
Hepatitis C1
Hepatitis C, Chronic1
Liver Diseases1
Non-alcoholic Fatty Liver Disease1
Thrombocytopenia1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.